Features of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer

被引：0
|
作者：
Argyriou, A. [1 ]
Polychronopoulos, P. [1 ]
Iconomou, G. [1 ]
Koutras, A. [1 ]
Gourzis, P. [1 ]
Assimakopoulos, K. [1 ]
Kalofonos, H. [1 ]
Chroni, E. [1 ]
机构：
[1] Univ Hosp Patras, Patras, Greece
来源：
JOURNAL OF NEUROLOGY | 2007年 / 254卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [31] Acupuncture for Oxaliplatin Chemotherapy-Induced Peripheral Neuropathy in Colon Cancer: A Retrospective Case Series
    Valentine-Davis, Brandy
    Altshuler, Laurence H.
    [J]. MEDICAL ACUPUNCTURE, 2015, 27 (03) : 216 - 223
  • [32] Outcome in disappearing colorectal cancer liver metastases during oxaliplatin-based chemotherapy
    Ono, Tomojiro
    Ishida, Hideyuki
    Kumamoto, Kensuke
    Okada, Norimichi
    Ishibashi, Keiichiro
    [J]. ONCOLOGY LETTERS, 2012, 4 (05) : 905 - 909
  • [33] Oxaliplatin-based chemotherapy inpatients with advanced pancreatic cancer
    Vattemi, E.
    Franchi, R.
    Pedersini, R.
    Tansini, G.
    Baier, S.
    Costa, P.
    Signaroldi, A.
    Zanaletti, F.
    Sbalzarini, G.
    Graiff, C.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 34 - 34
  • [34] ERCC1 and the Prognosis for Patients With Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
    Baek, Moo-Jun
    [J]. ANNALS OF COLOPROCTOLOGY, 2015, 31 (03) : 81 - 81
  • [35] PHARMACOGENETIC PREDICTORS OF SEVERE CHRONIC PERIPHERAL NEUROPATHY IN STAGE II-III COLON CANCER (CC) PATIENTS TREATED WITH OXALIPLATIN-BASED ADJUVANT CHEMOTHERAPY (CT). A GEMCAD STUDY
    Custodio, A.
    Moreno, J.
    Aparicio, J.
    Gallego Plazas, J.
    Fernandez Martos, C.
    Maurel, J.
    Ramos, D.
    Cejas, P.
    Madero, R.
    Feliu, J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 181 - 181
  • [36] Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
    Rubbia-Brandt, L
    Audard, V
    Sartoretti, P
    Roth, AD
    Brezault, C
    Le Charpentier, M
    Dousset, B
    Morel, P
    Soubrane, O
    Chaussade, S
    Mentha, G
    Terris, B
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (03) : 460 - 466
  • [37] PKM2 as a biomarker for sensitivity to oxaliplatin-based chemotherapy in metastatic colorectal cancer (mCRC).
    Papadaki, C.
    Saridaki, Z.
    Tzardi, M.
    Sfakianaki, M.
    Sfakiotaki, G.
    Trypaki, M.
    Messaritakis, I.
    Mavroudis, D.
    Georgoulias, V.
    Sougklakos, I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [38] Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy for metastatic colorectal cancer.
    Rubbia-Brandt, L
    Audard, V
    Sartoretti, P
    Roth, AD
    Brezault, C
    Lecharpentier, M
    Dousset, B
    Morel, P
    Soubrane, O
    Chaussade, S
    Mentha, G
    Terris, B
    [J]. HEPATOLOGY, 2003, 38 (04) : 696A - 696A
  • [39] Peripheral hepatic sinusoidal obstruction syndrome due to oxaliplatin-based chemotherapy
    Kobayashi, Shinichiro
    Okudaira, Sadayuki
    Kobayashi, Kazuma
    Kanetaka, Kengo
    Eguchi, Susumu
    [J]. CLINICAL CASE REPORTS, 2019, 7 (02): : 394 - 396
  • [40] Prognostic value of methylator phenotype in stage III colon cancer treated with oxaliplatin-based adjuvant chemotherapy
    Gallois, C.
    Taieb, J.
    Le Corre, D.
    Le Malicot, K.
    Tabernero, J.
    Mulot, C.
    Seitz, J-F.
    Aparicio, T.
    Folprecht, G.
    Lepage, C.
    Mini, E.
    Van Laethem, J-L.
    Emile, J. F.
    Laurent-Puig, P.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
12345